Gail M. Farfel, Chief Executive Officer at ProMIS Neurosciences Inc. (PMN), bought 1,000 shares at $5.70 ($6K) on 2022-12-06, disclosed to the SEC on 2022-12-08.
Open-market purchase of $6k PMN by Chief Executive Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| DRRX | BUY | 2022-05-13 | $8K | — | Filing → |
| DRRX | BUY | 2022-05-12 | $959 | — | Filing → |
| DRRX | BUY | 2022-05-10 | $9K | — | Filing → |